# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009263
Filing Date
2025-05-08
Accepted
2025-05-08 16:16:04
Documents
90
Period of Report
2025-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | form10-q.htm iXBRL | 10-Q | 1061017
2 | EX-31.1 | ex31-1.htm | EX-31.1 | 12442
3 | EX-31.2 | ex31-2.htm | EX-31.2 | 18178
4 | EX-32.1 | ex32-1.htm | EX-32.1 | 9738
| Complete submission text file | 0001641172-25-009263.txt |  | 7302079

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL SCHEMA FILE | hrow-20250331.xsd | EX-101.SCH | 53874
6 | XBRL CALCULATION FILE | hrow-20250331_cal.xml | EX-101.CAL | 73550
7 | XBRL DEFINITION FILE | hrow-20250331_def.xml | EX-101.DEF | 292545
8 | XBRL LABEL FILE | hrow-20250331_lab.xml | EX-101.LAB | 481726
9 | XBRL PRESENTATION FILE | hrow-20250331_pre.xml | EX-101.PRE | 411847
92 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1215144

Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Filer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 25926359
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)